Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.41 USD -7.21%
Market Cap: 39.1m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Intrinsic Value

CLGN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CLGN stock under the Base Case scenario is 15.33 USD. Compared to the current market price of 3.41 USD, Collplant Biotechnologies Ltd is Undervalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Collplant Biotechnologies Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for CLGN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CLGN?
Bearish
Neutral
Bullish

Fundamental Analysis

3.41 USD
-7.21%
-7.21%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Collplant Biotechnologies Ltd
IL
Biotechnology
Market Cap
39.1m USD
IPO
Sep 1, 1993
Employees
66
Israel
Market Cap
39.1m USD
Industry
Biotechnology
IPO
Sep 1, 1993
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Collplant Biotechnologies Ltd

Provide an overview of the primary business activities
of Collplant Biotechnologies Ltd.

What unique competitive advantages
does Collplant Biotechnologies Ltd hold over its rivals?

What risks and challenges
does Collplant Biotechnologies Ltd face in the near future?

Summarize the latest earnings call
of Collplant Biotechnologies Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Collplant Biotechnologies Ltd.

Provide P/S
for Collplant Biotechnologies Ltd.

Provide P/E
for Collplant Biotechnologies Ltd.

Provide P/OCF
for Collplant Biotechnologies Ltd.

Provide P/FCFE
for Collplant Biotechnologies Ltd.

Provide P/B
for Collplant Biotechnologies Ltd.

Provide EV/S
for Collplant Biotechnologies Ltd.

Provide EV/GP
for Collplant Biotechnologies Ltd.

Provide EV/EBITDA
for Collplant Biotechnologies Ltd.

Provide EV/EBIT
for Collplant Biotechnologies Ltd.

Provide EV/OCF
for Collplant Biotechnologies Ltd.

Provide EV/FCFF
for Collplant Biotechnologies Ltd.

Provide EV/IC
for Collplant Biotechnologies Ltd.

Show me price targets
for Collplant Biotechnologies Ltd made by professional analysts.

What are the Revenue projections
for Collplant Biotechnologies Ltd?

How accurate were the past Revenue estimates
for Collplant Biotechnologies Ltd?

What are the Net Income projections
for Collplant Biotechnologies Ltd?

How accurate were the past Net Income estimates
for Collplant Biotechnologies Ltd?

What are the EPS projections
for Collplant Biotechnologies Ltd?

How accurate were the past EPS estimates
for Collplant Biotechnologies Ltd?

What are the EBIT projections
for Collplant Biotechnologies Ltd?

How accurate were the past EBIT estimates
for Collplant Biotechnologies Ltd?

Compare the revenue forecasts
for Collplant Biotechnologies Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Collplant Biotechnologies Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Collplant Biotechnologies Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Collplant Biotechnologies Ltd compared to its peers.

Compare the P/E ratios
of Collplant Biotechnologies Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Collplant Biotechnologies Ltd with its peers.

Analyze the financial leverage
of Collplant Biotechnologies Ltd compared to its main competitors.

Show all profitability ratios
for Collplant Biotechnologies Ltd.

Provide ROE
for Collplant Biotechnologies Ltd.

Provide ROA
for Collplant Biotechnologies Ltd.

Provide ROIC
for Collplant Biotechnologies Ltd.

Provide ROCE
for Collplant Biotechnologies Ltd.

Provide Gross Margin
for Collplant Biotechnologies Ltd.

Provide Operating Margin
for Collplant Biotechnologies Ltd.

Provide Net Margin
for Collplant Biotechnologies Ltd.

Provide FCF Margin
for Collplant Biotechnologies Ltd.

Show all solvency ratios
for Collplant Biotechnologies Ltd.

Provide D/E Ratio
for Collplant Biotechnologies Ltd.

Provide D/A Ratio
for Collplant Biotechnologies Ltd.

Provide Interest Coverage Ratio
for Collplant Biotechnologies Ltd.

Provide Altman Z-Score Ratio
for Collplant Biotechnologies Ltd.

Provide Quick Ratio
for Collplant Biotechnologies Ltd.

Provide Current Ratio
for Collplant Biotechnologies Ltd.

Provide Cash Ratio
for Collplant Biotechnologies Ltd.

What is the historical Revenue growth
over the last 5 years for Collplant Biotechnologies Ltd?

What is the historical Net Income growth
over the last 5 years for Collplant Biotechnologies Ltd?

What is the current Free Cash Flow
of Collplant Biotechnologies Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Collplant Biotechnologies Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Collplant Biotechnologies Ltd

Current Assets 16.5m
Cash & Short-Term Investments 15.4m
Receivables 431k
Other Current Assets 695k
Non-Current Assets 5.9m
PP&E 5.7m
Intangibles 145k
Other Non-Current Assets 115k
Current Liabilities 3.1m
Accounts Payable 2.3m
Accrued Liabilities 798k
Non-Current Liabilities 2.5m
Other Non-Current Liabilities 2.5m
Efficiency

Earnings Waterfall
Collplant Biotechnologies Ltd

Revenue
650k USD
Cost of Revenue
-2.1m USD
Gross Profit
-1.5m USD
Operating Expenses
-16.9m USD
Operating Income
-18.3m USD
Other Expenses
925k USD
Net Income
-17.4m USD

Free Cash Flow Analysis
Collplant Biotechnologies Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CLGN Profitability Score
Profitability Due Diligence

Collplant Biotechnologies Ltd's profitability score is 9/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Negative Gross Profit
Negative 1-Year Revenue Growth
Declining ROE
9/100
Profitability
Score

Collplant Biotechnologies Ltd's profitability score is 9/100. The higher the profitability score, the more profitable the company is.

CLGN Solvency Score
Solvency Due Diligence

Collplant Biotechnologies Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Collplant Biotechnologies Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLGN Price Targets Summary
Collplant Biotechnologies Ltd

Wall Street analysts forecast CLGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLGN is 12.75 USD with a low forecast of 11.11 USD and a high forecast of 14.7 USD.

Lowest
Price Target
11.11 USD
226% Upside
Average
Price Target
12.75 USD
274% Upside
Highest
Price Target
14.7 USD
331% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CLGN?

Click here to dive deeper.

Dividends

Collplant Biotechnologies Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CLGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one CLGN stock?

The intrinsic value of one CLGN stock under the Base Case scenario is 15.33 USD.

Is CLGN stock undervalued or overvalued?

Compared to the current market price of 3.41 USD, Collplant Biotechnologies Ltd is Undervalued by 78%.

Back to Top